Last Updated: 19 April 2026
Ashmore Group plc (LSE: ASHM) is a London-listed, FTSE 250 specialist emerging markets asset manager founded by Mark Coombs in 1992. Revenue is entirely a function of assets under management, and AUM has halved from a USD 94bn peak in 2021 to USD 50.7bn at the end of March 2026. For the last two years the investment case has been a balance: a fortress balance sheet and an 8–10% dividend yield on one side, and a structurally challenged EM asset class with an uncovered dividend on the other. The last six months have added real news — a Japan Post Insurance partnership bringing USD 1bn of committed capital, a sharp improvement in H1 FY26 profit, and a modest Q3 FY26 AUM reversal.
1. Company Snapshot
| Item | Detail |
|---|---|
| Full name | Ashmore Group plc |
| Ticker / ISIN | LSE: ASHM / GB00B132NW22 |
| Sector / Industry | Financials / Specialist EM Asset Management |
| Founded | 1992 (IPO 2006) |
| Headquarters | London, United Kingdom |
| CEO | Mark Coombs (Founder) |
| Chairman | Clive Adamson |
| Group Finance Director | Tom Shippey |
| Market cap (19 April 2026) | ~£1.4 billion |
| Revenue (FY25, year to 30 June 2025) | £142.4 million |
| Adjusted net revenue (FY25) | £146.5 million |
| Profit after tax (FY25) | £93.7 million |
| Employees | ~294 (June 2025) |
| Exchange | London Stock Exchange (FTSE 250) |
| Website | ashmoregroup.com |
2. Bull Case vs Bear Case
Bull Case
- Inflection in flows. Net outflows slowed from USD 8.5bn in FY24 to USD 0.8bn in FY25. H1 FY26 saw net inflows of USD 2.3bn — the first meaningful positive flow number in years.
- Japan Post Insurance partnership (31 March 2026). USD 1bn capital commitment over 12 months and a 2.9% equity stake. Opens Japanese institutional distribution and signals external validation of the franchise.
- Fortress balance sheet. Zero debt. Over £750m of financial resources; excess capital above FCA Pillar II requirement exceeds £600m. Dividend is supported by the balance sheet even when earnings soften.
- High dividend yield. Full year FY25 dividend 16.9p maintained; at current share price the yield is ~8–10% depending on date. For income investors this is one of the highest yields on the FTSE 250.
- Founder alignment. Mark Coombs still holds roughly 30%+ of the company. Interests closely aligned with minority shareholders; limited appetite for dilutive M&A.
Bear Case
- AUM has halved. From ~USD 94bn peak (June 2021) to USD 50.7bn (March 2026). Q3 FY26 saw USD 1.8bn combined negative performance and outflow — a reminder the recovery is not linear.
- Dividend is uncovered. FY25 payout ratio ~98–104% of earnings and ~259% of operating cash flow. Sustainable for now via balance sheet, but not indefinitely.
- Fee compression. Net management fee margin drifted from ~38bps (H1 FY25) to ~34bps (H1 FY26). Passive EM ETFs at 10–20 bps continue to pressure active fees.
- Revenue down 24% year-on-year. FY25 revenue £142.4m vs £187m FY24. Cost discipline (operating costs -14% YoY) protected PBT, but further AUM declines would outpace cost-out capacity.
- Key-person risk. Mark Coombs (founder, ~30%+ holder, CEO since inception) has no publicly disclosed succession plan. The firm's identity, client relationships and investment philosophy are tightly bound to him.
3. What Does This Company Actually Do?
Ashmore is a pure-play specialist asset manager in emerging markets debt and equity. It runs active strategies on behalf of institutional clients — pension funds, insurance companies, central banks, sovereign wealth funds, other asset managers. There is no retail business, no passive business, no DC platform. Revenue is almost entirely management fees on fee-earning AUM, with a small and highly variable performance-fee stream.
| AUM theme (Q3 FY26, 31 March 2026) | AUM (USD bn) |
|---|---|
| External Debt (hard-currency EM sovereign / corporate) | 7.2 |
| Local Currency | 14.4 |
| Corporate Debt | 5.4 |
| Blended Debt | 12.1 |
| Total Fixed Income | ~39.1 |
| Equities | 7.8 |
| Alternatives | 1.8 |
| Total AUM | 50.7 |
FY25 net management fee margin was ~34–35 bps. Performance fees were £10.2m in FY25 (down from £22.7m in FY24); H1 FY26 performance fees £0.8m.
4. The Business Model
Capital-light, high-margin, active management. Historically the firm has run operating margins of 60–70% when AUM is stable. The cost base is dominated by compensation, plus technology, regulatory/compliance and London premises (office move underway).
| Margin metric | FY2025 | FY2024 |
|---|---|---|
| Adjusted EBITDA margin | 36% | ~42% |
| PBT margin (PBT / adj net revenue) | 74% | ~68% |
| Net management fee margin (bps) | ~34–35 | ~38 |
Moat. 30+ year EM-only specialism. Deep institutional relationships, local on-the-ground networks across Asia, Latam, Africa and EM Europe, and a substantial seed-capital programme that signals skin in the game and helps launch new strategies. Fee compression is the key long-term pressure.
Subsidy / regulatory credit dependency. None. Ashmore does not receive government subsidies or tax credits. It is subject to FCA prudential / Pillar II capital requirements; excess capital materially exceeds the minimum. No debt.
5. Financial Health
| FY (to 30 June) | AUM (USD bn, period end) | Revenue (£m) | PBT (£m) | Net income (£m) | EPS (p) | DPS (p) |
|---|---|---|---|---|---|---|
| FY21 | ~94.0 | — | — | — | — | — |
| FY24 | 49.3 | 187.0 | 127.8 | 100.0 | 13.94 | 16.9 |
| FY25 | 47.6 | 142.4 | 108.6 | 93.7 | 11.81 | 16.9 |
| H1 FY26 (to 31 Dec 2025) | 52.5 | — | 81.9 (+64% YoY) | — | 10.1 (diluted) | 4.8 (interim) |
| Q3 FY26 (31 Mar 2026) | 50.7 | — | — | — | — | — |
| Balance sheet / cash metrics | Latest |
|---|---|
| Debt | Zero |
| Total financial resources | >£750m |
| Excess capital above FCA Pillar II | >£600m (H1 FY26: £480m excess ~ 67p per share) |
| Shares in issue | ~715m (weighted average FY25) |
| Share buyback | No active programme disclosed |
Dividend. FY25 16.9p held flat despite lower earnings. H1 FY26 interim dividend held at 4.8p. Payout is ~98–104% of FY25 earnings and ~259% of operating cash flow — dividend currently being bridged by accumulated capital. Sustainable for some time given the balance sheet but the maths does not work indefinitely if AUM does not stabilise.
6. Valuation & Market Data
Sourced from public filings and market data providers as of 19 April 2026. Prices change intraday — see the ChartsView live charts for current prices.
| Metric | Value |
|---|---|
| Share price (mid-April 2026) | ~264–276p |
| Market cap | ~£1.4bn |
| P/E (trailing) | ~13–30x (wide range reflecting earnings volatility) |
| P/E (forward) | ~24x |
| EV/AUM | ~2.8% of AUM (market cap / USD 50.7bn) |
| Dividend yield | ~7.7–9.9% |
| 52-week high | ~276.54p (February 2026) |
| 52-week low | ~122.1p (April 2025) |
| Short interest | No material FCA-disclosed short positions |
| Most recent ex-dividend date | 26 February 2026 |
Shareholder composition: institutional ~69%, management/founders ~18–20%, other ~11–13%. Major holders include BlackRock (~10.7%), Vanguard (~9.5%), and Japan Post Insurance at 2.9% post the March 2026 partnership.
7. What Are They Building / What's Coming?
- Japan Post Insurance partnership (31 March 2026). USD 1bn committed capital over 12 months and a 2.9% stake. Management has framed this as a gateway to broader Japanese institutional distribution.
- EM outlook. Management's 2026 outlook emphasises attractive EM debt spreads, local-currency easing cycles in India, Brazil and Mexico, and compelling valuations in EM equity. It also flags Chinese property stress and US rate stickiness as key risks.
- Seed capital programme. Ongoing. Approximately USD 500m deployed over time; used to launch and scale new strategies.
- Capital returns. Progressive dividend policy retained; no active buyback disclosed.
- New London office. Relocation underway in 2025–26; operating cost headwind in the near term.
8. Competitive Landscape
| Peer | Model | Notes |
|---|---|---|
| Ninety One | Specialist EM equities & debt | Closest direct competitor; separately listed (LSE/JSE) |
| abrdn | Multi-asset with large EM franchise | Larger but diversified; own challenges with outflows |
| Jupiter | Active multi-asset with EM allocations | Competitor on EM debt & equity |
| Schroders | Global active asset manager | Strong EM franchise within a broader group |
| Man Group | Alternatives-led | EM exposure mostly via quant/alternatives |
| Federated Hermes | Multi-asset | EM fixed income capability |
| BlackRock / iShares | Passive EM ETFs (EMB, EEM etc.) | Main structural threat via fee compression |
Policy impact analysis. Two recent macro shifts matter for relative positioning. First, elevated US Treasury yields (10-year ~4.5%) have been a structural headwind for EM debt flows across the whole peer group — Ashmore, abrdn and Ninety One have all seen AUM pressure. Second, US trade policy shifts under Trump tariffs from 2025 pressured Mexican, Chinese and EM manufacturing exporter credits; active EM managers with local expertise (including Ashmore) theoretically have more tools to re-position than passive ETFs, but the flow impact has been symmetric on the downside. What is different about Ashmore vs peers is the capital light, debt-free balance sheet: in a downturn scenario Ashmore can hold its dividend for longer than most peers can.
9. Leadership and Ownership
Mark Coombs (CEO, Founder) built Ashmore out of an ANZ team he led a management buyout of in 1999 and took public in 2006. He still holds roughly 30%+ of the company and is the reference point for investment philosophy and client relationships. Tom Shippey (Group Finance Director) joined in 2007, ACA qualified, UBS investment banking background. Clive Adamson (Chairman) has a 40-year financial services career. Non-execs include Jennifer Bingham (accountant, Russian equity market background) and Thuy Dam (ANZ Asia / Vietnam banking).
Major shareholders. BlackRock ~10.7%, Vanguard ~9.5%, JP Morgan Asset Management a meaningful holder, Mark Coombs ~30%+, Japan Post Insurance 2.9%.
Recent insider / PDMR transactions
| Name | Date | Type | Shares | Plan type | Notes |
|---|---|---|---|---|---|
| Tom Shippey (FD) | 16 March 2026 | Share vesting (Executive Omnibus Incentive Plan) | 5,723 | Scheme-driven (not discretionary) | RNS Director/PDMR Shareholding |
| Employee Benefit Trust | 24 February 2025 | Transfer from 2004 EBT to 2024 EBT | — | Administrative restructuring | Not a signal |
There have been no material discretionary open-market purchases or sales by the CEO over the recent period. Mark Coombs previously sold ~10m shares in 2019 for £43.5m, reducing his holding from the 42.5% he held in 2007 to the current ~30%+.
10. Risks and Challenges
- EM asset-class outflows. AUM halved from peak. If US rates stay elevated, flows may not recover to 2020–21 levels.
- USD strength. A strong dollar pressures EM local-currency returns and often drives institutional reallocation away from EM.
- China property contagion. EM corporate and high-yield credit exposure carries real tail risk; Evergrande restructuring continues to unfold.
- EM sovereign defaults. Argentina, Venezuela and others create episodic portfolio losses.
- Fee compression. Passive EM ETFs at 10–20 bps keep squeezing active fee margins. Net fee margin already down 4 bps YoY.
- Dividend sustainability. Payout above earnings and well above cash flow. Balance sheet covers it for now; a cut, if it came, would drive a negative yield rerating.
- Key-person risk. Mark Coombs, founder-CEO, 30%+ owner, 30+ year tenure, no disclosed succession plan.
- Regulatory capital tightening. FCA prudential requirements could trend up; Ashmore is well inside current thresholds but the trajectory is tighter, not looser.
- Concentration risk. Institutional top-10 clients are likely 30–50% of AUM. Single large redemptions swing quarterly flows.
11. Recent Developments
Last 48 hours
- 17–18 April 2026: Trading in the ~264–276p range, consolidating after the 16 April AUM update.
- 16 April 2026: Q3 FY26 AUM update via RNS — AUM USD 50.7bn, down ~3% from the H1 peak of USD 52.5bn. Q3 movements: USD -0.9bn negative investment performance, USD -0.9bn net outflows. Modest reversal after a strong H1, but still well above the USD 47.6bn low at end of June 2025.
Previous 6 months
- 31 March 2026: Strategic partnership with Japan Post Insurance announced. USD 1bn capital commitment over 12 months; Japan Post takes 2.9% equity stake. Shares moved higher on the news, hitting a 52-week high of ~276.54p.
- 16 March 2026: Director/PDMR shareholding RNS — Tom Shippey share vesting (5,723 shares).
- 12 February 2026: H1 FY26 interim results. AUM USD 52.5bn (+10% vs June 2025). Profit before tax £81.9m (+64% YoY). Diluted EPS 10.1p (+89% YoY). Net inflows USD 2.3bn. Interim dividend maintained at 4.8p. £480m excess financial resources (£0.67/share).
- 26 February 2026: Most recent ex-dividend date.
- September 2025: FY25 full-year results. AUM USD 47.6bn (-1% YoY). Revenue £142.4m (-24% YoY). Adjusted net revenue £146.5m (-22% YoY). PBT £108.6m (-15% YoY). Basic EPS 11.81p (vs 13.94p). Full-year dividend held at 16.9p. Adjusted EBITDA margin 36%. Net outflows slowed from USD 8.5bn in FY24 to USD 0.8bn in FY25.
12. Key Dates Coming Up
- Mid-July 2026 — Q4 FY26 AUM update (via RNS), covering the quarter to 30 June 2026.
- Early September 2026 — FY26 full-year results presentation and annual report.
- Late July / August 2026 — Annual General Meeting (date TBC).
- Final FY26 ex-dividend — likely September/October 2026 (record date TBC).
- February 2027 — H1 FY27 interim results.
Follow upcoming RNS announcements via the ChartsView economic calendar and discuss Ashmore and other UK small/mid caps on the ChartsView forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.